Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
This is the second therapy approved under a new program that lets companies simultaneously apply for approval in multiple countries.
Space travel and chemotherapy affect the body similarly, and yet only astronauts undergo physical conditioning to help them stay strong.
A small study looked at response rates among those with HRAS-mutant head and neck carcinoma.
Zenocutuzumab targets tumors with a specific genetic alteration, making it potentially active against cancer at multiple locations.
A novel drug that blocks multiple cancer-causing mutations shows promise, especially for combination therapy.
A study in mice suggests that therapies approved for breast cancer may also combat other types, including colorectal and stomach cancer.
MRTX849 shrank tumors in half of lung cancer patients with a common but difficult to target mutation.
First targeted therapy may prolong survival of men with advanced prostate cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.